Business Description
Diagnos Inc
NAICS : 621999
SIC : 8639
ISIN : CA2524422078
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | -3.44 | |||||
Debt-to-Equity | -1.11 | |||||
Debt-to-EBITDA | -1.32 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -89.3 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.4 | |||||
3-Year EBITDA Growth Rate | 25.3 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | 25.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.81 | |||||
9-Day RSI | 51.56 | |||||
14-Day RSI | 51.17 | |||||
6-1 Month Momentum % | -22.78 | |||||
12-1 Month Momentum % | -18.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.7 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.39 | |||||
Days Sales Outstanding | 80.08 | |||||
Days Payable | 121 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -9.79 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -381.12 | |||||
Operating Margin % | -1297.45 | |||||
Net Margin % | -1551.53 | |||||
FCF Margin % | -1032.65 | |||||
ROA % | -293.76 | |||||
ROIC % | -470.75 | |||||
ROC (Joel Greenblatt) % | -1001.58 | |||||
ROCE % | -959.15 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 103.33 | |||||
EV-to-EBIT | -11.08 | |||||
EV-to-EBITDA | -11.6 | |||||
EV-to-Revenue | 143.31 | |||||
EV-to-Forward-Revenue | 4.82 | |||||
EV-to-FCF | -13.88 | |||||
Price-to-Median-PS-Value | 7.75 | |||||
Earnings Yield (Greenblatt) % | -9.03 | |||||
FCF Yield % | -8.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Diagnos Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.196 | ||
EPS (TTM) (C$) | -0.04 | ||
Beta | -0.38 | ||
Volatility % | 50.58 | ||
14-Day RSI | 51.17 | ||
14-Day ATR (C$) | 0.024103 | ||
20-Day SMA (C$) | 0.30675 | ||
12-1 Month Momentum % | -18.67 | ||
52-Week Range (C$) | 0.23 - 0.59 | ||
Shares Outstanding (Mil) | 81.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diagnos Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diagnos Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Diagnos Inc Frequently Asked Questions
What is Diagnos Inc(TSXV:ADK)'s stock price today?
When is next earnings date of Diagnos Inc(TSXV:ADK)?
Does Diagnos Inc(TSXV:ADK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |